Treatment is a maintenance therapy for certain patients with acute myeloid leukaemia Priothera – a company focused on the development of a sphingosine 1 phosphate …

During the research, SonoTran is being evaluated in patients with metastatic colorectal cancer. OxSonics Therapeutics – a company focused on cancer treatment through SonoTran – …

Therapy involves patients living with relapsed or refractory multiple myeloma. Takeda has announced that the National Institute for Health and Care Excellence (NICE) has recommended …

The new funding package will be used to progress NeoPhore’s expanding pipeline of therapies. NeoPhore – a small molecule neoantigen immuno-oncology company – has announced …

Biosimilar gains MHRA marketing authorisation for use throughout Britain. Stada and Xbrane have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has …

Industry-first cancer screening technology boosted by biomedical grant funding. SMi and the Medicines Discovery Catapult (MDC) have secured a biomedical catalyst (BMC) grant to establish …

MHRA approval relates to the company’s midlands-based drug development facilities. Celadon – a company focused on the development of cannabis-based medicines – has announced that …

Major industry names depart leaving UK pricing deal in serious jeopardy. Global pharma giants, AbbVie and Eli Lilly and Company (Lilly), have shocked the UK …

Green light for new asthma pen which offers a self-administration option across the EU. AstraZeneca’s (AZ) Tezspire has received a positive opinion from the European …

The company becomes the latest member of the ABPI and galvanises the company’s UK connections. Moderna is the latest member of the UK’s leading pharmaceutical …